Need a specific person's email?
Browse Fusion Pharmaceuticals's employee directory (about 61 employees) and reveal verified emails free.
Fusion Pharmaceuticals's most common email format is Last@fusionpharma.com (ex. Doe@fusionpharma.com), used for 82% of fusionpharma.com addresses. Fusion Pharmaceuticals uses 4 email patterns.
| Format | Example | Share of fusionpharma.com |
|---|---|---|
| Last@fusionpharma.comMost common | Doe@fusionpharma.com | |
| FLast@fusionpharma.com | JDoe@fusionpharma.com | |
| First.Last@fusionpharma.com | John.Doe@fusionpharma.com | |
| Middle@fusionpharma.com | Michael@fusionpharma.com |
Browse Fusion Pharmaceuticals's employee directory (about 61 employees) and reveal verified emails free.
Biotechnology ResearchOntario, Canada51-200 Employees
Fusion Pharmaceuticals is a clinical-stage biotechnology company focusing on oncology through radiopharmaceuticals. Its approach employs a proprietary Fast-Clear linker to attach alpha-emitting isotopes to antibodies and other targeting molecules, enabling focused delivery to tumors. Its lead candidate, FPI-1434, is being evaluated in a Phase 1 trial. The company is based in Hamilton, Ontario, with an office in Boston, Massachusetts, and serves oncology researchers and clinical developers seeking targeted radiopharmaceuticals. Fusion operates within the biotechnology research sector, specifically developing radiopharmaceuticals for cancer. In 2024, Fusion Pharmaceuticals was acquired by AstraZeneca.
Most common format
Last@fusionpharma.com
Example: Doe@fusionpharma.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.